Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound Danshen Dripping Pills for Diabetic Retinopathy
CTR20131517Phase 3Active
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd.
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Compound Danshen in diabetic retinopathy (DR), sponsored by Tasly Pharmaceutical Group Co., Ltd.. Started Jan 2014; status: active.
02
Drugs
Compound Danshen
03
Conditions
diabetic retinopathy (DR)
Beyond the preview
Go deeper on CTR20131517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131517.